Insulet Corporation $PODD Shares Sold by Curated Wealth Partners LLCDefense World · Oct 18, 2026
Here's Why Insulet (PODD) is a Strong Growth StockZacks Investment Research · Oct 16, 2026
Insulet Announces Omnipod Discover Now Available in U.S.Business Wire · Oct 12, 2026
Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026Business Wire · Oct 1, 2026
Why Insulet (PODD) is a Top Growth Stock for the Long-TermZacks Investment Research · Sep 25, 2026
Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain MomentumDefense World · Sep 25, 2026Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | $1.47 | $1.66 | Beat |
| May 6, 2026 | $1.19 | $1.42 | Beat |
| Feb 18, 2026 | $1.47 | $1.55 | Beat |
| Nov 6, 2025 | $1.14 | $1.24 | Beat |
| Aug 7, 2025 | $0.92 | $1.17 | Beat |
| May 8, 2025 | $0.79 | $1.02 | Beat |